Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum

AUTOR(ES)

Swanton, Eileithyia

FONTE

National Academy of Sciences

RESUMO

Pelizaeus–Merzbacher disease (PMD) is a dysmyelinating disease caused by mutations, deletions, or duplications of the proteolipid protein (PLP) gene. Mutant forms of PLP are retained in the endoplasmic reticulum (ER), and the resulting accumulation of mutant protein is thought to be a direct cause of oligodendrocyte cell death, which is the primary clinical feature of PMD. The molecular mechanisms underlying the toxicity of mutant PLP are however currently unknown. We report here that PMD-linked mutations of PLP are associated with the accelerated assembly of the protein into stable homooligomers that resemble mature, native PLP. Thus although WT PLP forms stable oligomers after an extended maturation period, most likely at the cell surface, mutant forms of PLP rapidly assemble into such oligomers at the ER. Using PLP mutants associated with diseases of varying severity, we show that the formation of stable oligomers correlates with the development of PMD. Based on these findings, we propose that the premature oligomerization of PLP in the ER of oligodendrocytes contributes to the pathology of PMD.

Documentos Relacionados

• Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein
• A functional analysis of disease-associated mutations in the androgen receptor gene
• Altered protein dynamics of disease-associated lamin A mutants
• The functional importance of disease-associated mutation
• The Sampling Distribution of Disease-Associated Alleles